EndoQuest Robotics Valuation, Funding & Investors

Restor3d is a Durham, North Carolina-headquartered medical device company specializing in 3D-printed orthopedic implants. The firm produces patient-specific titanium craniomaxillofacial plates, spinal spacers, and pelvic reconstruction devices using AI-optimized designs for osseointegration. FDA-cleared products serve surgeons at hospitals like Mayo Clinic, integrating digital planning software for precise anatomical fits in trauma and oncology cases.

Culture Biosciences is a San Francisco-headquartered biotech firm offering a cloud-connected biomanufacturing platform with robotic bioreactors. Its system enables parallel experimentation for process development in fermentation and cell culture, serving pharmaceutical and industrial biotech clients. Founded in 2016, the company has raised over $100 million in funding and operates a 20,000-square-foot facility in South San Francisco for high-throughput runs.

LightForce Orthodontics makes a fully personalized, 3D-printed braces system that uses AI and digital workflows to design custom brackets for each patient's anatomy. Orthodontists use the platform for treatment planning, from intraoral scans through final prescriptions, aiming to shorten treatment timelines and reduce the number of patient visits compared with standard orthodontics. The company manufactures its brackets in the United States, including at a facility in Wilmington, Massachusetts.

Graphy Inc is engaged in developing customized materials (3D printing materials) based on oligomer synthesis technology, photo-curable resins and materials for 3D printing in the dental industry. Its products include Shape Memory Aligner, Permanent C&B, Denture Base, Mouth Guard, and others.

Convergent Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, that develops radiopharmaceuticals for cancer treatment. Its lead program, CONV01-alpha, is a radioantibody that binds to prostate-specific membrane antigen to deliver a radioactive payload selectively to prostate cancer cells while sparing healthy tissue. The company is building a broader pipeline of similar radioantibody therapies targeting prostate cancer and other solid tumors.

Unlearn.AI is a clinical trial platform generating digital twins of patients using machine learning models trained on historical data. Its TwinRCT design accelerates biopharma studies by reducing required participants while maintaining statistical power for endpoints. Headquartered in San Francisco, the company partners with Pfizer and Roche on trials for Alzheimer's and oncology indications.

Butler National Corp is involved in the design, engineering, manufacturing, selling, integrating, installing, repairing, modifying, overhauling, servicing, and distributing portfolio of aerostructures, aircraft components, avionics, accessories, subassemblies, and systems (Aerospace Products). The group serves the aviation industry, including owners of aircraft and contractors involved with private, commercial, business, and government aircraft operations. It also serves commercial weapon manufacturers and suppliers to governments and their agencies. The company has two operating segments: Professional Services and Aerospace Products. Its main source of revenue comes from the Aerospace Products segment. It operates in North America, Europe, Asia, Australia, and other geographical regions.

Tess Holdings Co Ltd is engaged in the development and electricity sales of renewable power plants and power retailing business. Further, it is also involved in the operation and maintenance of cogeneration and other environmental energy-saving systems.

Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.

Alleviant Medical develops the Alleviant Heart Stabilizer, a transcatheter mitral valve repair device for congestive heart failure patients. Inserted via femoral artery access, the implant reshapes the mitral annulus to reduce regurgitation and improve cardiac output. Targeting the 6 million US heart failure cases, the system aims to cut hospital readmissions by 50 percent in clinical trials. Based in Tampa, Florida, the company raised Series A funding in 2021 and plans FDA pivotal studies.

SEDEMAC is a manufacturer of electronic control products for vehicles and equipment. The Pune-based firm, originating from IIT Bombay, produces millions of units annually for global markets in automotive and industrial applications. SEDEMAC develops in-house technologies at world-class facilities in India.

Aerin Medical is a Sunnyvale, California-headquartered health technology company developing radiofrequency devices for nasal airway treatments. Its VivAer system treats nasal obstruction, while RhinAer addresses chronic rhinitis by remodeling soft tissues in outpatient procedures. FDA-cleared in 2019 and 2020, the products equip ENT physicians in over 500 U.S. clinics as surgery alternatives.